Evaluation of Atacand® (Candesartan) in Daily Medical Practice

A 12-Week Open-Label Non-Interventional Evaluation of Atacand® (Candesartan) Efficacy, Tolerability, Compliance and Treatment Satisfaction in Patients With Arterial Hypertension

This open label, non-interventional study is to show the efficacy of antihypertensive treatment with Atacand in hypertensive patients. Efficacy is to be evaluated based on the difference in systolic and diastolic blood pressure at baseline and at both follow-up visits.

Inclusion Criteria:

• a patient with arterial hypertension who has been prescribed Atacand according to physician's judgement, irrespective of the inclusion in the study

Exclusion Criteria:

• hypersensitivity to candesartan or any other ingredient of Atacand
• liver function impairment and/or cholestasis
• severe renal insufficiency
• woman of child-bearing potential and not using appropriate contraceptive measures, pregnancy or lactation